Clinical Trials Logo

Clinical Trial Summary

Limb-girdle muscular dystrophies (LGMD) are a series of rare progressive genetic disorders that are characterized by wasting and weakness of the voluntary proximal muscles. The onset of the disease is usually at young age, and most patients will be wheelchair-bound due to the progressive deterioration. Since currently genetic therapies for this disease are still immature, better natural history and genotype-phenotype studies are needed for preparing future therapies.


Clinical Trial Description

This is multicentered-based, prospective, and observational study, which mainly focuses on the diagnosis and progression of limb-girdle muscular dystrophies (LGMD) in China. the investigators collect patient data including basic information, strength evaluations, genetic data, electromyography results, pathology imaging from muscle biopsies, and MRIs. Previously collected patient data may also be enrolled in this study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04989751
Study type Observational [Patient Registry]
Source Huashan Hospital
Contact
Status Enrolling by invitation
Phase
Start date July 7, 2021
Completion date December 1, 2026